Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer

Completed · Phase 1

Conditions studied: Liver Cancer, Metastatic Cancer

In brief

RATIONALE: Heating melphalan to several degrees above body temperature and infusing it to the affected area directly around the tumor may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of hepatic arterial infusion with melphalan in treating patients who have unresectable liver cancer.

Key facts

Study ID

NCT00030082

Run by

National Cancer Institute (NCI)

Starts

2001-07-01

Last updated by the study team

2015-04-30

Who can join

Age: 14 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.